Skip to content
Screener

Globus Medical GMED Q2 2026 earnings

Reported August 6, 2026 · After market close

Revenue$789.6MBeat by $6.7M
EPS$1.34Beat by $0.24
Revenue estimate$782.9M
EPS estimate$1.10
“Momentum continued into the second quarter with 6% overall revenue growth, or 9% growth excluding Nevro, driven by share gains across a majority of our underlying businesses, most notably US Spine, growing 7% and International Spine, growing 14% as-reported and 12% on a constant currency basis. The depth of our product portfolio and exclusive selling model positions us to lead with innovation and commercial outreach, driving our ability to grow share over the long-term. Our priority remains centered on achieving improved surgical outcomes through the Globus ecosystem, bringing together patient selection, surgical techniques with complementary implants and technology to drive the surgical procedure, through a closed-loop surgical intelligence ecosystem.”
Keith Pfeil

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$792.2M
EPS estimate$1.20

Financials

Q2 2026

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$10.1B+33.1%
Enterprise value$9.71B+29.7%
P/E18.9×-2.4×
P/S3.2×+0.3×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0×0.0×
Current ratio4.6×+0.5×

Segments

By product

See full
Musculoskeletal Solutions$763.5M—
Enabling Technologies$26.1M—

By segment

See full
Reportable Segment$789.6M+5.9%

FAQ

When did Globus Medical report Q2 2026 earnings?
Globus Medical (GMED) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Globus Medical's Q2 2026 revenue and EPS?
Globus Medical reported revenue of $789.6M and eps of $1.34 for Q2 2026.
Did Globus Medical beat estimates in Q2 2026?
Revenue beat the consensus estimate of $782.9M by $6.7M. EPS beat the consensus estimate of $1.10 by $0.24.
How did Globus Medical's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.9% from $745.3M a year earlier and eps grew 55.8% from $0.86.
Where can I find Globus Medical's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-054353) and the 10-Q periodic report (0001628280-26-054450) directly on SEC EDGAR. The filing index links above go to sec.gov.